Patient-reported outcomes and acceptability during messaging-based telemedicine follow-up for dry eye disease

Information from the abstract

Telemedicine may support longitudinal management of dry eye disease (DED) through remote communication and symptom monitoring. This prospective single-group pre–post study evaluated patient-reported outcomes and acceptability during 1 month of messaging-based telemedicine follow-up delivered through LINE as an adjunct to usual ophthalmic care. Ninety-six adults with clinically diagnosed DED were included; no concurrent control group was used. Mean Ocular Surface Disease Index (OSDI) score decreased from 32.29 ± 14.41 at baseline to 22.70 ± 11.92 at 1 month, with a mean paired reduction of 9.59 points (95% CI, 7.18–12.00; p < 0.001). DEQS also decreased, with a median paired reduction of 8.54 points (IQR, 1.67–15.94; BCa bootstrap 95% CI, 4.58–10.83; Wilcoxon signed-rank p < 0.001). In exploratory multivariable analysis, baseline behavioral factors were not independently associated with OSDI change, whereas higher baseline OSDI was associated with greater subsequent reduction. Ninety participants (93.8%) would use telemedicine again, and 91 (94.8%) reported overall satisfaction. Messaging-based follow-up was highly acceptable, and patient-reported outcomes improved during follow-up; however, these improvements cannot be attributed specifically to telemedicine because usual ophthalmic care continued and no concurrent control group was included.

Why this record is monitored

This record has an Impact Signal of 74/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: Ocular Surface and Contact Lens · Telemedicine and Telehealth Implementation · Ophthalmology and Visual Health Research